Overall, we can infer that the use of IL-10 can treat SARS-CoV-2–induced ARDS and pulmonary fibrosis through the anti-viral THαβ immunological pathway, which was previously discussed [105]. The gene discussed is IL10; the disease is acute respiratory distress syndrome.